The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors

Oncogene

Volumn 27, Issue 14, 2008, Pages 2035-2044

  Caramel, J ^a,b   Medjkane, S ^a,b,c   Quignon, F ^a,b   Delattre, O ^a,b  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Adipocyte; Differentiation; Rhabdoid tumor suppressor; SNF5 INI1; SWI SNF

Indexed keywords

ADENOSINE TRIPHOSPHATASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROTEIN C EBPBETA; PROTEIN SNF5; PROTEIN SWI; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNF; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOID TUMOR;

MURINAE;

EID: 41149178203     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210847     Document Type: Article

References (40)

1. Albanese P, Belin MF, Delattre O. (2006). The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells. Eur J Cancer 42: 2326-2334.
2. Betz BL, Strobeck MW, Reisman DN, Knudsen ES, Weissman BE. (2002). Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G(1) arrest associated with induction of p16ink4a and activation of RB. Oncogene 21: 5193-5203.
3. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B. (1999). Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59: 74-79.
4. Carlson M, Laurent BC. (1994). The SNF/SWI family of global transcriptional activators. Curr Opin Cell Biol 6: 396-402.
5. Chai J, Lu X, Godfrey V, Fletcher C, Roberts CW, Van Dyke T et al. (2007). Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation. Cancer Res 67: 3002-3009.
6. de la Serna IL, Ohkawa Y, Imbalzano AN. (2006). Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers. Nat Rev Genet 7: 461-473.
7. Dennis JE, Charbord P. (2002). Origin and differentiation of human and murine stroma. Stem Cells 20: 205-214.
8. Farmer SR. (2006). Transcriptional control of adipocyte formation. Cell Metab 4: 263-273.
9. Gresh L, Bourachot B, Reimann A, Guigas B, Fiette L, Garbay S et al. (2005). The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation. EMBO J 24: 3313-3324.
10. Guidi CJ, Sands AT, Zambrowicz BP, Turner TK, Demers DA, Webster W et al. (2001). Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol Cell Biol 21: 3598-3603.
11. Hata K, Nishimura R, Ueda M, Ikeda F, Matsubara T, Ichida F et al. (2005). A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. Mol Cell Biol 25: 1971-1979.
12. Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP. (1994). Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266: 2002-2006.
13. Kashiwagi M, Morgan BA, Georgopoulos K. (2007). The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny. Development 134: 1571-1582.
14. Klochendler-Yeivin A, Fiette L, Barra J, Muchardt C, Babinet C, Yaniv M. (2000). The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep 1: 500-506.
15. Klochendler-Yeivin A, Picarsky E, Yaniv M. (2006). Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex. Mol Cell Biol 26: 2661-2674.
16. Kowenz-Leutz E, Leutz A. (1999). A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Mol Cell 4: 735-743.
17. Krabbe C, Zimmer J, Meyer M. (2005). Neural transdifferentiation of mesenchymal stem cells - a critical review. Apmis 113: 831-844.
18. Lane MD, Tang QQ, Jiang MS. (1999). Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochem Biophys Res Commun 266: 677-683.
19. Lee MC, Park SK, Lim JS, Jung S, Kim JH, Woo YJ et al. (2002). Atypical teratoid/rhabdoid tumor of the central nervous system: clinico-pathological study. Neuropathology 22: 252-260.
20. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. (2004). Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6: 483-495.
21. Medjkane S, Novikov E, Versteege I, Delattre O. (2004). The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization. Cancer Res 64: 3406-3413.
22. Muchardt C, Sardet C, Bourachot B, Onufryk C, Yaniv M. (1995). A human protein with homology to Saccharomyces cerevisiae SNF5 interacts with the potential helicase hbrm. Nucleic Acids Res 23: 1127-1132.
23. Pedersen TA, Kowenz-Leutz E, Leutz A, Nerlov C. (2001). Cooperation between C/EBPalpha TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation. Genes Dev 15: 3208-3216.
24. Phelan ML, Sif S, Narlikar GJ, Kingston RE. (1999). Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 3: 247-253.
25. Roberts CW, Galusha SA, McMenamin ME, Fletcher CD, Orkin SH. (2000). Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci USA 97: 13796-13800.
26. Roberts CW, Leroux MM, Fleming MD, Orkin SH. (2002). Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5. Cancer Cell 2: 415-425.
27. Roberts CW, Orkin SH. (2004). The SWI/SNF complex - chromatin and cancer. Nat Rev Cancer 4: 133-142.
28. Rosen ED, MacDougald OA. (2006). Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7: 885-896.
29. Saladin R, Fajas L, Dana S, Halvorsen YD, Auwerx J, Briggs M. (1999). Differential regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis. Cell Growth Differ 10: 43-48.
30. Salma N, Xiao H, Mueller E, Imbalzano AN. (2004). Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor gamma nuclear hormone receptor. Mol Cell Biol 24: 4651-4663.
31. Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. (1999). Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 65: 1342-1348.
32. Sif S, Saurin AJ, Imbalzano AN, Kingston RE. (2001). Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. Genes Dev 15: 603-618.
33. Takashima Y, Era T, Nakao K, Kondo S, Kasuga M, Smith AG et al. (2007). Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 129: 1377-1388.
34. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. (1994). mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8: 1224-1234.
35. 1-S transition of the cell cycle. Oncogene 21: 6403-6412.
36. Versteege I, Sevenet N, Lange J, Rousseau-Merck MF, Ambros P, Handgretinger R et al. (1998). Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394: 203-206.
37. Vries RG, Bezrookove V, Zuijderduijn LM, Kia SK, Houweling A, Oruetxebarria I et al. (2005). Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev 19: 665-670.
38. Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR et al. (1996). Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J 15: 5370-5382.
39. Young DW, Pratap J, Javed A, Weiner B, Ohkawa Y, van Wijnen A et al. (2005). SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation. J Cell Biochem 94: 720-730.
40. Zhang ZK, Davies KP, Allen J, Zhu L, Pestell RG, Zagzag D et al. (2002). Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Mol Cell Biol 22: 5975-5988.